Navigation Links
Not all lung cancer patients who could benefit from crizotinib are identified by FDA-approved test
Date:8/28/2012

Break apart a couple worm-like chromosomes and they may reconnect with mismatched tips and tails such is the case of the EML4-ALK fusion gene that creates 2-7 percent of lung cancers. Almost exactly a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were likely never smokers. Informed doctors use the test called a FISH assay to check for the EML4-ALK fusion gene, and then if the test is positive, ALK+ patients benefit greatly from crizotinib.

A recent University of Colorado Cancer Center case study published in the Journal of Thoracic Oncology describes the never-before-seen case of a patient who tested negative for EML4-ALK fusion based on the well-defined criteria for FISH assay as approved by FDA, but nevertheless experienced remission after treatment with crizotinib.

"The case implies that not all patients who might benefit from the drug are captured by the FDA-approved FISH assay. Perhaps despite the FDA pairing of crizotinib with FISH, other assays or other criteria for ALK/FISH positivity could be used," says paper co-author, Fred R. Hirsch, MD, PhD, investigator at the CU Cancer Center and professor of medical oncology and pathology at the CU School of Medicine.

In fact, it was by chance that after the patient's negative FISH, Hirsch and colleagues chose to look deeper. Besides using FISH to stain sections of chromosomes with the EML4-ALK fusion gene, the team used immunohistochemistry to look for the protein products of this fusion gene not the faulty plans but the faulty results. Sure enough, in this case, the patient had the EML4-ALK fusion protein but apparently without the typical EML4-ALK fusion gene that should code for it.

The team looked deeper, using next-gen sequencing to discover what, exactly, was going on in the short arm of chromosome number 2, which harbors the EML4-ALK fusion gene. What they found looked less like a pair of clean breaks that reatta
'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Breast Cancer Drug Might Help Men on Prostate Cancer Therapy
2. Reducing the side effects of treatment for prostate cancer
3. Accuracy of narrow band imaging with colonoscopy allows for distal non-cancerous polyps to be left in place
4. Daily Aspirin May Help Fight Prostate Cancer, But Not Breast Cancer
5. WSU researcher documents links between nutrients, genes and cancer spread
6. Excess Pounds Raise Risk of Breast Cancer Recurrence, Death: Study
7. Johns Hopkins team finds ICU misdiagnoses may account for as many annual deaths as breast cancer
8. Compounds activate key cancer enzyme to interfere with tumor formation
9. Lack of sleep found to be a new risk factor for aggressive breast cancers
10. Cancer vaccine Special Focus series published in Human Vaccines & Immunotherapeutics
11. Obese and overweight women face increased risk of recurrence of most common type of breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 According to a May 14, ... More Options for Breast Cancer Surgery,” modern medical technology has ... approach this disease in a whole new light. Since the ... now face breast cancer and mastectomies with greater ... “Before the introduction of plastic surgery to oncology, women had ...
(Date:5/22/2013)... next two decades, the cost of treating strokes in ... topping more than $180 billion a year, according to ... an aging population. The report, from the American Heart ... May 22 in the journal Stroke . ... Bruce Ovbiagele, chairman of the department of neurology at ...
(Date:5/22/2013)... 22, 2013 Recent tragedies including ... the school shooting in Newtown, Connecticut all resulted ... , Emergency medical practitioners train to respond ... Emergency Medical Services for Children (EMSC) Program specifically ... for the youngest patients. It is estimated 30 ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 HR Strategies ... hosted at the Gwinnett County Fairgrounds, on Friday May ... before, they far surpassed expectations; raising over $6,300 for ... sponsor for the event, donating the first $3,000 for ... , challenged the internal staff to match the company’s ...
(Date:5/22/2013)... Alan Mozes HealthDay Reporter , , WEDNESDAY, May ... number of American children who die each year awaiting ... research reveals. And increasing numbers of children are receiving ... of potential organ donors expanded to include not just ... a "circulatory determination of death." But it,s unclear ...
Breaking Medicine News(10 mins):Health News:Breast Augmentation – New Option for Breast Cancer Surgeries 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:HR Strategies Raises Over $6,300 for Cancer Research via Relay For Life 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4
... SALT LAKE CITY, Jan. 5 Health-conscious consumers who ... day now have a smaller,more powerful alternative to fish ... MegaRed delivers essential omega-3 fatty acids combined with,powerful antioxidants, ... supporting,heart health. One MegaRed softgel per day -- which ...
... VIEW, Calif., Jan. 5 Based on its ... Sullivan recognizes Toshiba,America Medical Systems with the 2008 ... The company has launched a variety of,cardiovascular imaging ... cardiac ultrasound line. This product has taken,echocardiography a ...
... Treat Diseases (HTDS) www.htdsmedical.com Further to the ... company addressed several targeted merger candidates, the company is ... negotiations with Slavica Bio Chem, www.slavicabiochem.com (Slavica). ... Renuyu Biochem, a USA and a UK company, founded ...
... IRVING, Texas, Jan. 5 RBC Life Sciences ... has elected current president, John W. Price, to CEO ... is currently CEO, will remain as chairman of the ... RBC Life Sciences, a global provider of proprietary nutritional ...
... Licenses PDL,s Queen et al. Patents for Soliris(R) INCLINE VILLAGE, ... (Nasdaq: PDLI ) and Alexion Pharmaceuticals, Inc. ... the companies have entered into a definitive license agreement and ... to Alexion,s humanized antibody, Soliris(R) (eculizumab) and PDL,s patents known ...
... Jan. 5 The Ensign Group, Inc. (Nasdaq: ... has acquired Southland Healthcare Center, a 150-bed skilled ... effective January 1, 2009. The facility has been ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO )"This is a strategic acquisition, and ...
Cached Medicine News:Health News:Three Times More Powerful Than Fish Oil, MegaRed(TM) Omega-3 Krill Oil Now Available Nationwide 2Health News:Three Times More Powerful Than Fish Oil, MegaRed(TM) Omega-3 Krill Oil Now Available Nationwide 3Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 2Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 3Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 4Health News:Hard To Treat Diseases (HTDS) Completes E Europe Merger 2Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 2Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 3Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 2Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 3Health News:The Ensign Group Acquires Texas Skilled Nursing Facility 2
(Date:5/22/2013)... May 22, 2013 Ranbaxy Laboratories Limited ... Ltd. (hereafter, Daiichi Sankyo), announced on May 22 ... years to address past conduct under prior management ... Daiichi Sankyo continues to support Ranbaxy in ... of the past which led to the investigations ...
(Date:5/22/2013)...  Grifols, ein globales Unternehmen der Gesundheitsbranche ... , Spanien, präsentierte die Ergebnisse einer Studie, ... PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des Alpha1-Proteins ... Niveau anhebt, das innerhalb des für gesunde ... eine lebensbedrohliche, genetische Erkrankung, bei der der ...
(Date:5/22/2013)... Israel , May 22, 2013 /PRNewswire/ ... leading developer and provider of microRNA-based molecular diagnostics, announces ... and Chief Executive Officer of Rosetta Genomics, will deliver ... taking place from June 3-6, 2013 in New York ... June 4 th at 2:00 p.m. Eastern time. ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
Medicine Products: